In conclusion, nephrotoxicity is a common and potentially clinically significant problem with cyclosporine and FK506 following transplantation. Further definition of its pathogenesis and improved dosing strategies for both of these drugs may reduce the impact of nephrotoxicity on both short-term and long-term outcomes.
|Original language||English (US)|
|Number of pages||9|
|Journal||Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|
|Issue number||5 Suppl 1|
|State||Published - Sep 1995|
ASJC Scopus subject areas